"New Anti-Obesity Medications Should Be Considered Preventive Health Care", Health Affairs Forefront, July 5, 2024 . DOI: 10.1377/forefront.20240702.323360 Caption. 1101 Connecticut Ave ...

Treatment of obesity makes sense and should save us money in the long run. Robert Lustig, MD, MSL, Department of Pediatrics, UCSF The problem with GLP-1 agonists is that they take our eye off the ...

The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.

Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of employers are considering covering the blockbuster weight-loss drugs ...

Although Medicare coverage of anti-obesity medicines would be important for all older Americans, it is extra important for Black Americans, who are more likely to be living with obesity.

CBO projects that 12.5 million Medicare beneficiaries would be able to receive an anti-obesity medication in 2026 if coverage were expanded. Though it estimates that only about 300,000, or 2%, of ...